CXCL8, a primary mediator of inflammatory responses, plays a role in systemic inflammation, and reducing CXCL8 levels could inhibit COPD inflammation (Castellucci et al., 2015). This evidence concerns the gene CXCL8 and chronic obstructive pulmonary disease.